Financials in USD. Standardized financial statements.
A compact view of how Tekla Life Sciences Investors turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $86.39M | $86.69M | $39.39M | $31.86M | $45.02M | $39.07M | $2.44M | $1.99M | $69.81M | $6.29M |
| Revenue Growth? | -0.3% | +120.1% | +23.6% | -29.2% | +15.2% | +1500.9% | +22.9% | -97.2% | +1009.6% | 0.0% |
| Cost of Revenue? | $0 | $0 | $5.24M | $5.55M | $6.08M | $5.21M | $0 | $0 | $4.61M | $4.95M |
| Gross Profit? | $86.39M | $86.69M | $18.28M | $26.31M | $38.95M | $33.87M | $2.44M | $1.99M | $65.20M | $1.34M |
| Gross Margin? | +100.0% | +100.0% | +46.4% | +82.6% | +86.5% | +86.7% | +100.0% | +100.0% | +93.4% | +21.3% |
| Operating Expenses? | $791,573 | $1.39M | $1.17M | $1.35M | $1.16M | $1.03M | $5.32M | $5.59M | $1.26M | $13.35M |
| Operating Income? | $85.59M | $85.30M | -$5.24M | -$104.60M | $64.53M | $123.05M | -$2.88M | -$3.61M | -$3.88M | -$3.79M |
| EBITDA? | $85.59M | $87.22M | $49.95M | -$101.62M | $68.68M | $123.06M | $0 | $0 | $68.56M | $0 |
| Income Before Tax | $85.59M | $85.30M | $22.35M | -$104.60M | $64.53M | $123.05M | -$70.48M | $28.66M | $68.56M | -$11.91M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3 | $0 |
| Net Income? | $85.59M | $85.30M | $22.35M | -$104.60M | $64.53M | $123.05M | -$70.48M | $28.66M | $68.56M | -$11.91M |
| EPS? | $2.96 | $3.04 | $0.79 | $-4.07 | $2.66 | $5.16 | $-3.04 | $1.28 | $3.21 | $1.00 |
| Diluted EPS? | $2.96 | $3.04 | $0.79 | $-4.07 | $2.66 | $5.16 | $-3.04 | $1.28 | $3.21 | $-0.57 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality